Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine.

ABSTRACT:

SUBMITTER: Shen P 

PROVIDER: S-EPMC5906233 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature